IL116601A - 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them - Google Patents

4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them

Info

Publication number
IL116601A
IL116601A IL116601A IL11660192A IL116601A IL 116601 A IL116601 A IL 116601A IL 116601 A IL116601 A IL 116601A IL 11660192 A IL11660192 A IL 11660192A IL 116601 A IL116601 A IL 116601A
Authority
IL
Israel
Prior art keywords
hydrogen
alkyl
independently
phenyl
phsophonates
Prior art date
Application number
IL116601A
Other languages
English (en)
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of IL116601A publication Critical patent/IL116601A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
IL116601A 1991-12-27 1992-12-25 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them IL116601A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/814,741 US5187173A (en) 1991-12-27 1991-12-27 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
IL10422992A IL104229A (en) 1991-12-27 1992-12-25 2-saccharinylmethyl and 4, 5, 6, 7-tetrahydro-2-saccharinylmethyl phosphates phosphonates and phosphinates and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IL116601A true IL116601A (en) 1997-04-15

Family

ID=25215883

Family Applications (3)

Application Number Title Priority Date Filing Date
IL116601A IL116601A (en) 1991-12-27 1992-12-25 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them
IL10422992A IL104229A (en) 1991-12-27 1992-12-25 2-saccharinylmethyl and 4, 5, 6, 7-tetrahydro-2-saccharinylmethyl phosphates phosphonates and phosphinates and pharmaceutical compositions containing them
IL11660195A IL116601A0 (en) 1991-12-27 1995-12-28 4, 5, 6, 7 tetrahydro-2-saccharinylmethyl phosphates phosphonates and phosphinates and pharmaceutical compositions containing them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL10422992A IL104229A (en) 1991-12-27 1992-12-25 2-saccharinylmethyl and 4, 5, 6, 7-tetrahydro-2-saccharinylmethyl phosphates phosphonates and phosphinates and pharmaceutical compositions containing them
IL11660195A IL116601A0 (en) 1991-12-27 1995-12-28 4, 5, 6, 7 tetrahydro-2-saccharinylmethyl phosphates phosphonates and phosphinates and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US5187173A (https=)
EP (1) EP0549073B1 (https=)
JP (1) JPH05271262A (https=)
AT (1) ATE150755T1 (https=)
AU (1) AU648938B2 (https=)
CA (1) CA2085427A1 (https=)
CZ (1) CZ371692A3 (https=)
DE (1) DE69218568T2 (https=)
DK (1) DK0549073T3 (https=)
ES (1) ES2100274T3 (https=)
FI (1) FI925875A7 (https=)
GR (1) GR3023632T3 (https=)
HU (1) HUT63630A (https=)
IL (3) IL116601A (https=)
MX (1) MX9207542A (https=)
MY (1) MY106897A (https=)
NO (1) NO303639B1 (https=)
NZ (1) NZ245585A (https=)
RU (1) RU2091377C1 (https=)
SG (1) SG48310A1 (https=)
SK (1) SK371692A3 (https=)
TW (1) TW225538B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5541168A (en) * 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
CN100430052C (zh) * 2002-03-05 2008-11-05 默克弗罗斯特加拿大有限公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
GEP20074230B (en) * 2002-03-20 2007-11-12 Bristol Myers Squibb Co Phosphate prodrugs of fluorooxindoles
US7488848B2 (en) * 2005-03-21 2009-02-10 Virobay, Inc. Alpha ketoamide compounds as cysteine protease inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
JPH026496A (ja) * 1988-06-27 1990-01-10 Ishihara Sangyo Kaisha Ltd 有機リン酸アミド系化合物、それらの製造方法及びそれらを含有する有害動物防除剤
KR0183397B1 (ko) * 1989-05-04 1999-05-01 존 엠. 스피나토 단백질 분해 효소 저해제로서 유용한 사카린 유도체들 및 그의 제조방법
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Also Published As

Publication number Publication date
AU648938B2 (en) 1994-05-05
US5187173A (en) 1993-02-16
DK0549073T3 (da) 1997-10-06
FI925875A0 (fi) 1992-12-23
HUT63630A (en) 1993-09-28
EP0549073A1 (en) 1993-06-30
IL104229A0 (en) 1993-05-13
NO924991L (no) 1993-06-28
GR3023632T3 (en) 1997-08-29
CA2085427A1 (en) 1993-06-28
DE69218568D1 (de) 1997-04-30
TW225538B (https=) 1994-06-21
IL116601A0 (en) 1996-03-31
FI925875L (fi) 1993-06-28
NO924991D0 (no) 1992-12-23
RU2091377C1 (ru) 1997-09-27
FI925875A7 (fi) 1993-06-28
IL104229A (en) 1997-02-18
NO303639B1 (no) 1998-08-10
MX9207542A (es) 1993-06-01
EP0549073B1 (en) 1997-03-26
ES2100274T3 (es) 1997-06-16
SK371692A3 (en) 1995-05-10
JPH05271262A (ja) 1993-10-19
NZ245585A (en) 1995-05-26
SG48310A1 (en) 1998-04-17
AU2829492A (en) 1993-07-01
HU9204123D0 (en) 1993-04-28
MY106897A (en) 1995-08-30
ATE150755T1 (de) 1997-04-15
CZ371692A3 (en) 1994-04-13
DE69218568T2 (de) 1997-11-13

Similar Documents

Publication Publication Date Title
UA27100A1 (uk) Заміщеhі піроли, що мають активhість іhгібіторів протеіhкіhази с, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі і фармацевтичhа композиція
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
AP9701041A0 (en) Pyridylpyrrole compounds.
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
MY103233A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
ZA842185B (en) New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof
UA50762C2 (uk) Похідні арилгліцинаміду та фармацевтична композиція
IL116601A (en) 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them
MX9701955A (es) Antagonistas de neuroquinina.
ZA919030B (en) Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them
HU9601217D0 (en) Antracyclinone derivatives and their use for treating amyloidosis
HUT76790A (en) 2-oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
AP9300561A0 (en) Antibiotic compounds.
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
IL88742A (en) Hiv inhibiting compositions containing polyhydroxy derivatives of pyrrolidine and certain novel derivatives thereof
DE3466991D1 (en) Penems, pharmaceutical compositions containing them, and process for their preparation
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
RU2091378C1 (en) 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition
CY2160B1 (en) Erburnane derivatives processes for their preparation and pharmaceutical compositions containing them
GR3031621T3 (en) Vulcanization accelerators.
AU2067592A (en) New n-(isoquinolin-5-ylsulphonyl)azacycloalkanes, process for the preparation thereof, and pharmaceutical compositions containing them
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
IL75887A (en) 9-substituted-indolo(6,5,4-cd)indole derivatives,their preparation and pharmaceutical compositions containing them
ES8605269A1 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees